LC
BIO icon

Lindbrook Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Lindbrook Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-69
Closed -$22.7K – 2797
2024
Q4 		$22.7K Sell
69
-5
-7% -$1.7K ﹤0.01% 1212
2024
Q3 		$24.8K Buy
74
+28
+61% +$8.89K ﹤0.01% 1175
2024
Q2 		$12.6K Sell
46
-13
-22% -$3.78K ﹤0.01% 1505
2024
Q1 		$20.4K Buy
59
+4
+7% +$1.31K ﹤0.01% 1198
2023
Q4 		$17.8K Buy
55
+39
+244% +$12.2K ﹤0.01% 1243
2023
Q3 		$5.74K Buy
16
+2
+14% +$772 ﹤0.01% 1703
2023
Q2 		$5.31K Sell
14
-20
-59% -$8.14K ﹤0.01% 1771
2023
Q1 		$16.3K Buy
34
+11
+48% +$5.15K ﹤0.01% 1176
2022
Q4 		$9.67K Buy
23
+10
+77% +$4.04K ﹤0.01% 1450
2022
Q3 		$5K Sell
13
-4
-24% -$1.99K ﹤0.01% 1641
2022
Q2 		$8K Sell
17
-2
-11% -$1.04K ﹤0.01% 1336
2022
Q1 		$11K Buy
19
+2
+12% +$1.21K ﹤0.01% 1238
2021
Q4 		$13K Sell
17
-2
-11% -$1.5K ﹤0.01% 1157
2021
Q3 		$14K Buy
19
+1
+6% +$749 ﹤0.01% 858
2021
Q2 		$12K Hold
18
– – ﹤0.01% 971
2021
Q1 		$10K Buy
18
+2
+13% +$1.18K ﹤0.01% 1009
2020
Q4 		$9K Hold
16
– – ﹤0.01% 935
2020
Q3 		$8K Buy
16
+1
+7% +$507 ﹤0.01% 900
2020
Q2 		$7K Hold
15
– – ﹤0.01% 948
2020
Q1 		$5K Buy
15
+2
+15% +$735 ﹤0.01% 968
2019
Q4 		$5K Buy
13
+6
+86% +$2.12K ﹤0.01% 1092
2019
Q3 		$2K Buy
+7
New +$2.28K ﹤0.01% 1239

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lindbrook Capital's BIO Position: Q1 2025 in Review

Lindbrook Capital sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2025, closing a stake of 69 shares — an estimated $22.7K sold.

Lindbrook Capital first reported a position in BIO in Q3 2019 and held it in 22 quarters. The position peaked at $24.8K in Q3 2024. 436 funds tracked by Wall St. Rank hold BIO as of Q1 2025.

  • Lindbrook Capital reported no remaining Bio-Rad Laboratories Class A position as of Q1 2025 after selling out during the quarter.
  • Lindbrook Capital sold 69 Bio-Rad Laboratories Class A shares in Q1 2025, an estimated $22.7K.
  • Lindbrook Capital first reported a position in Bio-Rad Laboratories Class A in Q3 2019 and held it in 22 quarters.
  • Lindbrook Capital's Bio-Rad Laboratories Class A position peaked at $24.8K in Q3 2024.
  • 436 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.